BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 15172125)

  • 1. Evidence that BRCA1- or BRCA2-associated cancers are not inevitable.
    Levin B; Lech D; Friedenson B
    Mol Med; 2012 Dec; 18(1):1327-37. PubMed ID: 22972572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions.
    Kraakman-van der Zwet M; Overkamp WJ; van Lange RE; Essers J; van Duijn-Goedhart A; Wiggers I; Swaminathan S; van Buul PP; Errami A; Tan RT; Jaspers NG; Sharan SK; Kanaar R; Zdzienicka MZ
    Mol Cell Biol; 2002 Jan; 22(2):669-79. PubMed ID: 11756561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The breast cancer susceptibility gene BRCA2 is required for the maintenance of telomere homeostasis.
    Min J; Choi ES; Hwang K; Kim J; Sampath S; Venkitaraman AR; Lee H
    J Biol Chem; 2012 Feb; 287(7):5091-101. PubMed ID: 22187435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome instability and carcinogenesis: insights from murine models of human pancreatic cancer associated with BRCA2 inactivation.
    Cassidy LD; Liau SS; Venkitaraman AR
    Mol Oncol; 2014 Mar; 8(2):161-8. PubMed ID: 24268522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma.
    Doherty RE; Bryant HE; Valluru MK; Rennie IG; Sisley K
    Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31480356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era.
    Macedo GS; Alemar B; Ashton-Prolla P
    Genet Mol Biol; 2019; 42(1 suppl 1):215-231. PubMed ID: 31067289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA 1/2 gene mutation and gastrointestinal stromal tumours: a potential association.
    Waisbren J; Uthe R; Siziopikou K; Kaklamani V
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26150619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced FANCD2 influences spontaneous SCE and RAD51 foci formation in uveal melanoma and Fanconi anaemia.
    Gravells P; Hoh L; Solovieva S; Patil A; Dudziec E; Rennie IG; Sisley K; Bryant HE
    Oncogene; 2013 Nov; 32(46):5338-46. PubMed ID: 23318456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haploinsufficiency in mouse models of DNA repair deficiency: modifiers of penetrance.
    Cabelof DC
    Cell Mol Life Sci; 2012 Mar; 69(5):727-40. PubMed ID: 21952828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage repair is unaffected by mimicked heterozygous levels of BRCA2 in HT-29 cells.
    Tannenbaum B; Mofunanya T; Schoenfeld AR
    Int J Biol Sci; 2007 Sep; 3(7):402-7. PubMed ID: 17940634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotoxic and cytotoxic studies of beta-sitosterol and pteropodine in mouse.
    Paniagua-Pérez R; Madrigal-Bujaidar E; Reyes-Cadena S; Molina-Jasso D; Gallaga JP; Silva-Miranda A; Velazco O; Hernández N; Chamorro G
    J Biomed Biotechnol; 2005; 2005(3):242-7. PubMed ID: 16192682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brh2-Dss1 interplay enables properly controlled recombination in Ustilago maydis.
    Kojic M; Zhou Q; Lisby M; Holloman WK
    Mol Cell Biol; 2005 Apr; 25(7):2547-57. PubMed ID: 15767662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutional genomic instability with inversions, duplications, and amplifications in 9p23-24 in BRCA2 mutation carriers.
    Savelyeva L; Claas A; Matzner I; Schlag P; Hofmann W; Scherneck S; Weber B; Schwab M
    Cancer Res; 2001 Jul; 61(13):5179-85. PubMed ID: 11431357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower level of BRCA2 protein in heterozygous mutation carriers is correlated with an increase in DNA double strand breaks and an impaired DSB repair.
    Arnold K; Kim MK; Frerk K; Edler L; Savelyeva L; Schmezer P; Wiedemeyer R
    Cancer Lett; 2006 Nov; 243(1):90-100. PubMed ID: 16448746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic rearrangements in the BRCA1 and BRCA2 genes.
    Mazoyer S
    Hum Mutat; 2005 May; 25(5):415-22. PubMed ID: 15832305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitfalls and caveats in BRCA sequencing.
    Bellosillo B; Tusquets I
    Ultrastruct Pathol; 2006; 30(3):229-35. PubMed ID: 16825125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased rates of spontaneous sister chromatid exchange in lymphocytes of BRCA2+/- carriers of familial breast cancer clusters.
    Kim MK; Zitzmann S; Westermann F; Arnold K; Brouwers S; Schwab M; Savelyeva L
    Cancer Lett; 2004 Jul; 210(1):85-94. PubMed ID: 15172125
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.